Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label Phase 2 Study to Evaluate the Efficacy and Safety of ASK0912 for Injection Versus Polymyxin B for Injection in Adult Patients With Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

NCT07759934 is registered in ClinicalTrials.gov with Jiangsu Aosaikang Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07759934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07759934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label Phase 2 Study to Evaluate the Efficacy and Safety of ASK0912 for Injection Versus Polymyxin B for Injection in Adult Patients With Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Lead sponsor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
March 25, 2026
Completion date
December 25, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospital-acquired bacterial pneumonia (habp), ventilator-associated bacterial pneumonia (vabp)